Clinical Trial Update: Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating VS-101 in combination with chemoradiotherapy for head and neck squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• VS-101

Snippet

Sponsor: VSPharmTech Co.,Ltd. | Conditions: Head and Neck Cancer Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING